Plan of action to strengthen the surveillance and control of leishmaniasis in the Americas 2023–2030
Date
2024-10-18ISBN
978-92-75-12878-7 (PDF) 978-92-75-12879-4 (print version)
Metadata
Show full item recordAbstract
In order to update, systematize and monitor the leishmaniasis actions at the operational level, this new version of the Plan of Action for the period of 2023-2030 has been developed, which contains actions for the surveillance, assistance and control of leishmaniases in the Region. The main elements discussed include evidence, cost, cost-effectiveness of available interventions, access to and analysis of epidemiological and process data, as well as the organization of health services in the countries of the Americas. In addition, the goals and indicators of the Plan were developed based on technical discussions, consensus, orientations and suggestions made by experts, researchers and professionals responsible for actions to fight the disease in endemic countries. The proposed targets for leishmaniases control in the Region are ambitious and will require countries and partners interested in providing support to work hard and achieve them. The actions proposed in this Plan were developed based on the diagnosis of the disease situation in the Region, where leishmaniasis was initially divided into two groups according to its clinical form: cutaneous and mucosal leishmaniasis and visceral leishmaniasis. Both differ in the species of Leishmania, vectors, reservoirs, and clinical presentation, as well as in the socioeconomic and environmental characteristics that determine the risks and different transmission cycles, leading to different surveillance and control actions. These actions are focused on early diagnosis, adequate treatment and follow-up of affected people, surveillance, prevention, and control of human cases, vector, and reservoirs, when required, along with education and communication efforts.
Pages
78 p.
Subject
Citation
Pan American Health Organization. Plan of action to strengthen the surveillance and control of leishmaniasis in the Americas 2023–2030. Washington, D.C.: PAHO; 2024. Available from: https://doi.org/10.37774/9789275128787.
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2019)Vector-borne diseases such as dengue, Zika, chikungunya, malaria, and leishmaniasis, among others, have a great impact on public health. This makes it necessary to step up entomological surveillance to guide prevention and ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2020)In the Americas, leishmaniasis are a public health problem due to their magnitude and geographic distribution and because they produce clinical forms that can cause death, disability, and mutilation. In recent years, the ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2021)The Pan American Health Organization (PAHO) continues to support endemic countries in order to achieve the objectives of controlling and eliminating leishmaniasis as a public health problem in the Region, in accordance ...